Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty

Authors not listed

Shanghai East Hospital · 2020

Stem-cell exhaustion Stem-cell therapy Human Randomized controlled trial

Abstract

The purpose of this clinical study is to answer the questions: 1. Is the proposed intervention safe? 2. Is the proposed intervention effective in improving the healthy status of subjects with aging frailty?

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2020). A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty. <em>Shanghai East Hospital</em>. https://clinicaltrials.gov/study/NCT04314011

Vancouver

Anonymous. A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty. Shanghai East Hospital. 2020.

BibTeX

@misc{anon2020AMulti, title = {A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty}, author = {Anonymous}, journal = {Shanghai East Hospital}, year = {2020}, }